
### [MONDO:0003225](http://purl.obolibrary.org/obo/MONDO_0003225)
**Label:** bone marrow disease

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0009692](http://purl.obolibrary.org/obo/MONDO_0009692) (primary myelofibrosis), [MONDO:0016540](http://purl.obolibrary.org/obo/MONDO_0016540) (congenital secondary polycythemia), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0015253](http://purl.obolibrary.org/obo/MONDO_0015253) (Diamond-Blackfan anemia), [MONDO:0019454](http://purl.obolibrary.org/obo/MONDO_0019454) (refractory anemia with excess blasts), [MONDO:0016541](http://purl.obolibrary.org/obo/MONDO_0016541) (acquired secondary polycythemia), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0019452](http://purl.obolibrary.org/obo/MONDO_0019452) (chronic myeloproliferative disease, unclassifiable), [MONDO:0008785](http://purl.obolibrary.org/obo/MONDO_0008785) (pyridoxine-refractory autosomal recessive sideroblastic anemia), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0019391](http://purl.obolibrary.org/obo/MONDO_0019391) (Fanconi anemia), [MONDO:0005029](http://purl.obolibrary.org/obo/MONDO_0005029) (essential thrombocythemia), [MONDO:0013878](http://purl.obolibrary.org/obo/MONDO_0013878) (pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1), [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0013879](http://purl.obolibrary.org/obo/MONDO_0013879) (pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2), [MONDO:0016828](http://purl.obolibrary.org/obo/MONDO_0016828) (autosomal recessive sideroblastic anemia), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), [MONDO:0011118](http://purl.obolibrary.org/obo/MONDO_0011118) (acute myeloid leukemia), [MONDO:0016599](http://purl.obolibrary.org/obo/MONDO_0016599) (autosomal dominant secondary polycythemia), [MONDO:0012197](http://purl.obolibrary.org/obo/MONDO_0012197) (aplastic anemia), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), [MONDO:0020312](http://purl.obolibrary.org/obo/MONDO_0020312) (atypical chronic myeloid leukemia), [MONDO:0020115](http://purl.obolibrary.org/obo/MONDO_0020115) (secondary polycythemia), [MONDO:0010419](http://purl.obolibrary.org/obo/MONDO_0010419) (X-linked sideroblastic anemia), [MONDO:0007896](http://purl.obolibrary.org/obo/MONDO_0007896) (acute monocytic leukemia), [MONDO:0020076](http://purl.obolibrary.org/obo/MONDO_0020076) (myeloproliferative neoplasm), [MONDO:0005571](http://purl.obolibrary.org/obo/MONDO_0005571) (polycythemia), [MONDO:0005171](http://purl.obolibrary.org/obo/MONDO_0005171) (chronic myeloproliferative disorder), [MONDO:0013667](http://purl.obolibrary.org/obo/MONDO_0013667) (myelodysplastic syndrome), 

**Corr. equiv. classes:** [Orphanet:86839](http://www.orpha.net/ORDO/Orphanet_86839), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [Orphanet:124](http://www.orpha.net/ORDO/Orphanet_124), [Orphanet:238536](http://www.orpha.net/ORDO/Orphanet_238536), [Orphanet:255132](http://www.orpha.net/ORDO/Orphanet_255132), [Orphanet:52688](http://www.orpha.net/ORDO/Orphanet_52688), [OMIM:151380](http://purl.obolibrary.org/obo/OMIM_151380), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:86830](http://www.orpha.net/ORDO/Orphanet_86830), [Orphanet:247511](http://www.orpha.net/ORDO/Orphanet_247511), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318), [OMIM:205950](http://purl.obolibrary.org/obo/OMIM_205950), [Orphanet:519](http://www.orpha.net/ORDO/Orphanet_519), [Orphanet:98836](http://www.orpha.net/ORDO/Orphanet_98836), [OMIM:611783](http://purl.obolibrary.org/obo/OMIM_611783), [Orphanet:514](http://www.orpha.net/ORDO/Orphanet_514), [OMIM:609135](http://purl.obolibrary.org/obo/OMIM_609135), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [Orphanet:71493](http://www.orpha.net/ORDO/Orphanet_71493), [Orphanet:88](http://www.orpha.net/ORDO/Orphanet_88), [Orphanet:98274](http://www.orpha.net/ORDO/Orphanet_98274), [Orphanet:238547](http://www.orpha.net/ORDO/Orphanet_238547), [Orphanet:84](http://www.orpha.net/ORDO/Orphanet_84), [OMIM:300331](http://purl.obolibrary.org/obo/OMIM_300331), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [OMIM:300751](http://purl.obolibrary.org/obo/OMIM_300751), [OMIM:182170](http://purl.obolibrary.org/obo/OMIM_182170), [OMIM:614286](http://purl.obolibrary.org/obo/OMIM_614286), [OMIM:131440](http://purl.obolibrary.org/obo/OMIM_131440), [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [OMIM:254450](http://purl.obolibrary.org/obo/OMIM_254450), [OMIM:614742](http://purl.obolibrary.org/obo/OMIM_614742), [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [OMIM:614743](http://purl.obolibrary.org/obo/OMIM_614743), [OMIM:609820](http://purl.obolibrary.org/obo/OMIM_609820), [Orphanet:98427](http://www.orpha.net/ORDO/Orphanet_98427), [Orphanet:98428](http://www.orpha.net/ORDO/Orphanet_98428), [Orphanet:824](http://www.orpha.net/ORDO/Orphanet_824), [Orphanet:314701](http://www.orpha.net/ORDO/Orphanet_314701), [Orphanet:98824](http://www.orpha.net/ORDO/Orphanet_98824), [Orphanet:260305](http://www.orpha.net/ORDO/Orphanet_260305), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), [Orphanet:75563](http://www.orpha.net/ORDO/Orphanet_75563), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), 

**Class expressions from DL-Learner:**

- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology))) 48.12%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract))) 46.73%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0012374](http://purl.obolibrary.org/obo/HP_0012374) (Abnormality of the globe))) 44.93%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology))) 44.93%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality))) 44.93%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma))) 44.93%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia))) 41.63%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000498](http://purl.obolibrary.org/obo/HP_0000498) (Blepharitis))) 41.63%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000225](http://purl.obolibrary.org/obo/HP_0000225) (Gingival bleeding))) 41.63%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000112](http://purl.obolibrary.org/obo/HP_0000112) (Nephropathy))) 41.24%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000085](http://purl.obolibrary.org/obo/HP_0000085) (Horseshoe kidney))) 41.24%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 40.86%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 40.86%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 40.86%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 40.86%


